(19)
(11) EP 4 739 397 A1

(12)

(43) Date of publication:
13.05.2026 Bulletin 2026/20

(21) Application number: 24748732.5

(22) Date of filing: 02.07.2024
(51) International Patent Classification (IPC): 
A61P 35/00(2006.01)
C07D 471/08(2006.01)
C07D 471/18(2006.01)
C07D 498/04(2006.01)
A61K 31/506(2006.01)
A61K 31/553(2006.01)
A61K 31/5365(2006.01)
A61K 31/5386(2006.01)
C07D 471/04(2006.01)
C07D 471/10(2006.01)
C07D 487/04(2006.01)
C07D 498/18(2006.01)
A61K 31/551(2006.01)
A61K 31/519(2006.01)
A61K 31/5517(2006.01)
A61K 31/55(2006.01)
(52) Cooperative Patent Classification (CPC):
C07D 471/08; C07D 471/04; C07D 471/10; C07D 471/18; C07D 487/04; C07D 498/18; C07D 498/04; A61P 35/00
(86) International application number:
PCT/US2024/036492
(87) International publication number:
WO 2025/010245 (09.01.2025 Gazette 2025/02)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 06.07.2023 IN 202341045361

(71) Applicant: Exelixis, Inc.
Alameda, CA 94502 (US)

(72) Inventors:
  • ABBINENI, Chandrasekhar
    Hyderabad Telangana 500 072 (IN)
  • SAMAJDAR, Susanta
    Bangalore Karnataka 560078 (IN)
  • AELURI, Madhu
    Bangalore Karnataka 560078 (IN)
  • SIMONOVICH, Scott
    Oakland, California 94602 (US)

(74) Representative: Mathys & Squire 
32 London Bridge Street The Shard
London SE1 9SG
London SE1 9SG (GB)

   


(54) FUSED PYRAZOLE DERIVATIVES AS USP1 INHIBITORS